Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patients
出版年份 2013 全文链接
标题
Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patients
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 14, Issue 7, Pages 799-811
出版商
Future Medicine Ltd
发表日期
2013-05-08
DOI
10.2217/pgs.13.54
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metastatic Colon Cancer, Version 3.2013
- (2017) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Pharmacokinetic evaluation of capecitabine in breast cancer
- (2013) Gennaro Daniele et al. Expert Opinion on Drug Metabolism & Toxicology
- Dermatologic Presentations of Orthopedic Pathologies
- (2012) Daniel Marchalik et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Comparison of pharmacokinetics and safety profiles of two capecitabine tablet formulations in patients with colon, colorectal or breast cancer
- (2012) Siddharth Chachad et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Individual Fluorouracil Dose Adjustment in FOLFOX Based on Pharmacokinetic Follow-Up Compared With Conventional Body-Area-Surface Dosing: A Phase II, Proof-of-Concept Study
- (2012) Olivier Capitain et al. Clinical Colorectal Cancer
- Population Pharmacokinetic Analysis of 5-FU and 5-FDHU in Colorectal Cancer Patients: Search for Biomarkers Associated with Gastro-Intestinal Toxicity
- (2012) Christian Woloch et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial
- (2012) Christophe Tournigand et al. JOURNAL OF CLINICAL ONCOLOGY
- Modeling the 5-Fluorouracil Area Under the Curve Versus Dose Relationship to Develop a Pharmacokinetic Dosing Algorithm for Colorectal Cancer Patients Receiving FOLFOX6
- (2012) R. R. Kaldate et al. ONCOLOGIST
- Pharmacokinetic adaptation of 5-fluorouracil: where are we and where are we going?
- (2012) Michèle Boisdron-Celle PHARMACOGENOMICS
- Target Concentration Intervention in Oncology
- (2012) Mohamed Saleem et al. THERAPEUTIC DRUG MONITORING
- Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency
- (2011) Maurice C. van Staveren et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer
- (2011) M. J. Deenen et al. CLINICAL CANCER RESEARCH
- Adjuvant treatment of colon cancer: what is next?
- (2011) Katherine Van Loon et al. CURRENT OPINION IN ONCOLOGY
- Time-Dependent Pharmacokinetics of 5-Fluorouracil and Association With Treatment Tolerability in the Adjuvant Setting of Colorectal Cancer
- (2011) Toni Ibrahim et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity
- (2011) Ursula Amstutz et al. PHARMACOGENOMICS
- AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
- (2011) C. Hiemke et al. PHARMACOPSYCHIATRY
- Routine Dihydropyrimidine Dehydrogenase Testing for Anticipating 5-Fluorouracil–Related Severe Toxicities: Hype or Hope?
- (2010) Joseph Ciccolini et al. Clinical Colorectal Cancer
- Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity
- (2010) André B. P. van Kuilenburg et al. HUMAN GENETICS
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes
- (2009) M. Wasif Saif et al. JNCI-Journal of the National Cancer Institute
- Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal Cancer
- (2008) Erick Gamelin et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group
- (2008) Matthias Schwab et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetics of 5-Fluorouracil in Patients Heterozygous for the IVS14+1G > A Mutation in the Dihydropyrimidine Dehydrogenase Gene
- (2008) A. B. P. van Kuilenburg et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Once-Daily Intravenous Busulfan with Therapeutic Drug Monitoring Compared to Conventional Oral Busulfan Improves Survival and Engraftment in Children Undergoing Allogeneic Stem Cell Transplantation
- (2007) Imke H. Bartelink et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started